288 related articles for article (PubMed ID: 27391066)
1. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression.
Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z
Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066
[TBL] [Abstract][Full Text] [Related]
2. miR-130b regulates B cell proliferation via CYLD-mediated NF-κB signaling.
Wu M; Zhao J; Wu W; Hao C; Yang Y; Zhang J
Exp Cell Res; 2024 Jan; 434(1):113870. PubMed ID: 38049082
[TBL] [Abstract][Full Text] [Related]
3. miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD.
Xiao ZQ; Yin TK; Li YX; Zhang JH; Gu JJ
Oncol Rep; 2017 Jul; 38(1):167-174. PubMed ID: 28534976
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-3713 regulates bladder cell invasion via MMP9.
Wu WB; Wang W; Du YH; Li H; Xia SJ; Liu HT
Sci Rep; 2016 Aug; 6():32374. PubMed ID: 27577949
[TBL] [Abstract][Full Text] [Related]
5. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
6. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis.
Zhang L; Ding Y; Yuan Z; Liu J; Sun J; Lei F; Wu S; Li S; Zhang D
Oncotarget; 2015 Feb; 6(4):2483-95. PubMed ID: 25595906
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
10. TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.
Song L; Liu L; Wu Z; Li Y; Ying Z; Lin C; Wu J; Hu B; Cheng SY; Li M; Li J
J Clin Invest; 2012 Oct; 122(10):3563-78. PubMed ID: 23006329
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of m
Wang J; Tan L; Jia B; Yu X; Yao R; OUYang N; Yu X; Cao X; Tong J; Chen T; Chen R; Li J
Int J Biol Sci; 2021; 17(10):2633-2651. PubMed ID: 34326699
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling.
Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W
J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516
[TBL] [Abstract][Full Text] [Related]
13. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
14. KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-κB signaling.
Yuan H; Wei S; Ren Z; Li F; Liu B; Liu R; Zhang X
Int Immunopharmacol; 2023 Jan; 114():109202. PubMed ID: 36538852
[TBL] [Abstract][Full Text] [Related]
15. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
Ling T; Yu F; Cao H
Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
[TBL] [Abstract][Full Text] [Related]
18. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
Yang J; Yuan D; Li J; Zheng S; Wang B
Tumour Biol; 2016 Apr; 37(4):4331-41. PubMed ID: 26494000
[TBL] [Abstract][Full Text] [Related]
19. The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
Zhang X; Liu X; Jing Z; Bi J; Li Z; Liu X; Li J; Li Z; Zhang Z; Kong C
Cancer Gene Ther; 2020 Apr; 27(3-4):189-202. PubMed ID: 30723269
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression.
Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X
FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
